Related references
Note: Only part of the references are listed.CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production
Wei Zeng et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2014)
Nuclear Factor κB-Dependent Regulation of Angiogenesis, and Metastasis in an In Vivo Model of Thyroid Cancer Is Associated With Secreted Interleukin-8
Kevin T. Bauerle et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Immunohistochemical evaluation of midkine and nuclear factor-kappa B as diagnostic biomarkers for papillary thyroid cancer and synchronous metastasis
Yujie Zhang et al.
LIFE SCIENCES (2014)
Histone deacetylase inhibitor (HDACI) mechanisms of action: Emerging insights
Prithviraj Bose et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Curcumin Enhances Docetaxel-Induced Apoptosis of 8505C Anaplastic Thyroid Carcinoma Cells
Jung Min Hong et al.
ENDOCRINOLOGY AND METABOLISM (2014)
Activation of nuclear factor-kappa B contributes to growth and aggressiveness of papillary thyroid carcinoma
Jung-Soo Pyo et al.
PATHOLOGY RESEARCH AND PRACTICE (2013)
The Nuclear Factor Kappa-B Signaling Pathway as a Therapeutic Target Against Thyroid Cancers
Xinying Li et al.
THYROID (2013)
Targeting nuclear factor-kappa B to overcome resistance to chemotherapy
P. Godwin et al.
FRONTIERS IN ONCOLOGY (2013)
Nuclear factor-kappa B inhibition can enhance therapeutic efficacy of 131I on the in vivo management of differentiated thyroid cancer
Zhaowei Meng et al.
LIFE SCIENCES (2012)
Nuclear Factor-Kappa B Inhibition Can Enhance Apoptosis of Differentiated Thyroid Cancer Cells Induced by 131I
Zhaowei Meng et al.
PLOS ONE (2012)
Imatinib Enhances Docetaxel-Induced Apoptosis Through Inhibition of Nuclear Factor-κB Activation in Anaplastic Thyroid Carcinoma Cells
EunSook Kim et al.
THYROID (2012)
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
Robert C. Smallridge et al.
THYROID (2012)
Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis
Atsuko Sato et al.
CANCER SCIENCE (2011)
High Efficacy of Concomitant Treatment of Undifferentiated (Anaplastic) Thyroid Cancer with Radiation and Docetaxel
Marlene Troch et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Detailed Molecular Fingerprinting of Four New Anaplastic Thyroid Carcinoma Cell Lines and Their Use for Verification of RhoB as a Molecular Therapeutic Target
Laura A. Marlow et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion
Kevin T. Bauerle et al.
MOLECULAR CANCER (2010)
Lack of Therapeutic Effect of the Histone Deacetylase Inhibitor Vorinostat in Patients with Metastatic Radioiodine-Refractory Thyroid Carcinoma
Jennifer A. Woyach et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification
Rebecca E. Schweppe et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype
Wilma C. G. van Staveren et al.
CANCER RESEARCH (2007)
Inhibitors of NF-κB signaling:: 785 and counting
T. D. Gilmore et al.
ONCOGENE (2006)
Sulforhodamine B colorimetric assay for cytotoxicity screening
Vanicha Vichai et al.
NATURE PROTOCOLS (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Expression of nuclear factor-κB and IκBα proteins in prostatic adenocarcinomas:: Correlation of nuclear factor-κB immunoreactivity with disease recurrence
JS Ross et al.
CLINICAL CANCER RESEARCH (2004)
Blocking anti-apoptosis as a strategy for cancer chemotherapy:: NF-κB as a target
NR Monks et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Selective activation of NF-κB subunits in human breast cancer:: potential roles for NF-κB2/p52 and for Bcl-3
PC Cogswell et al.
ONCOGENE (2000)
Share Paper
